{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:58:37Z","timestamp":1774274317108,"version":"3.50.1"},"reference-count":242,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Regenerative Medicine"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/17460751.2026.2634720","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:20:04Z","timestamp":1773231604000},"page":"67-89","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Quality control strategy for differentiating induced pluripotent stem cells into pancreatic \u03b2-cells before transplantation"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-8688","authenticated-orcid":false,"given":"Francisco","family":"Sotomayor Lugo","sequence":"first","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7833-956X","authenticated-orcid":false,"given":"Mays Amer","family":"Abuhantash","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-4197","authenticated-orcid":false,"given":"Gisela Maria","family":"Suarez Formigo","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]},{"name":"United Arab Emirates University","place":["Al Ain, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1981-8024","authenticated-orcid":false,"given":"Sharmin","family":"Haideri","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6215-7774","authenticated-orcid":false,"given":"Lucia","family":"Tomiyama","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-9602","authenticated-orcid":false,"given":"Grinand","family":"Luc","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9224-6065","authenticated-orcid":false,"given":"Masaru","family":"Niidate","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9797-0607","authenticated-orcid":false,"given":"Liping","family":"Sun","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7558-8097","authenticated-orcid":false,"given":"Nataly","family":"Iglesias Barrameda","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0398-6346","authenticated-orcid":false,"given":"Tania","family":"Grinan Ramirez","sequence":"additional","affiliation":[{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5373-3414","authenticated-orcid":false,"given":"Yendry","family":"Ventura Carmenate","sequence":"additional","affiliation":[{"name":"United Arab Emirates University","place":["Al Ain, UAE"]},{"name":"Abu Dhabi Stem Cells Center","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030422"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112277"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.34172\/hpp.2020.18"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v7.i1.174"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.01.015"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0242"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-024-10838-9"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-022-00125-8"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2023.e00784"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.05.022"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/rme-2018-0095"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadva.2025.100151"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101773"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072435"},{"key":"e_1_3_7_17_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Safety testing of human allogeneic cells expanded for use in cell-based medical products. Docket number: FDA-2024-D-1243. US Food and Drug Administration. 2024 [cited 2025 Dec 1] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/safety-testing-human-allogeneic-cells-expanded-use-cell-based-medical-products"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.02.021"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2016.12.003"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048677"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1593207"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.043"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061470"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxac020"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-025-03952-8"},{"key":"e_1_3_7_26_1","first-page":"2161","article-title":"The contribution of next generation sequencing technologies to epigenome research of stem cell and tumorigenesis","volume":"2","author":"Li J","year":"2011","unstructured":"Li J, Wang T, Zhang X, et al. The contribution of next generation sequencing technologies to epigenome research of stem cell and tumorigenesis. Hum Genet Embryol S. 2011;2:2161\u20132436.","journal-title":"Hum Genet Embryol S"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2014.592"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.ima03bs111"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2023.11.008"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6960-9_1"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/fft2.44"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.117"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050799"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-201-4_16"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1084-8_15"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1242\/bio.022111"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2019.101434"},{"key":"e_1_3_7_38_1","unstructured":"Committee for Medicinal Products for Human Use (CHMP). Guideline on human cell-based medicinal products. Doc. Ref. EMEA\/CHMP\/410869\/2006. European Medicines Agency. 2008 [cited 2025 Dec 1] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-human-cell-based-medicinal-products_en.pdf"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3999-3_5"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26707-8"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3387"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-4276-4_2"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24183"},{"key":"e_1_3_7_44_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Human gene therapy products incorporating human genome editing. Guidance for industry. Docket number: FDA-2021-D-0398. US Food and Drug Administration. 2024 [cited 2025 Dec 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/human-gene-therapy-products-incorporating-human-genome-editing"},{"key":"e_1_3_7_45_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Guidance for human somatic cell therapy and Gene therapy. Guidance for industry. Docket number: FDA-2009-D-0132\u20130016. US Food and Drug Administration. 1998 [cited 2025 Dec 1] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-human-somatic-cell-therapy-and-gene-therapy"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.050150"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-016-9662-8"},{"key":"e_1_3_7_48_1","unstructured":"International Organization for Standardization (ISO). Biotechnology \u2014 biobanking \u2014 General requirements for biobanking (ISO 20387: 2018). ISO. 2018 [cited 2025 Dec 1] Available from: https:\/\/www.iso.org\/standard\/67888.html"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56569-4"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.11.005"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1835"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2015.1053467"},{"key":"e_1_3_7_53_1","first-page":"2020","article-title":"Biological insights from the whole genome analysis of human embryonic stem cells","author":"Merkle FT","year":"2020","unstructured":"Merkle FT, Ghosh S, Genovese G, et al. Biological insights from the whole genome analysis of human embryonic stem cells. bioRxiv. 2020:2020\u201310.","journal-title":"bioRxiv"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-16-7589-8_9"},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.15406\/jsrt.2017.02.00078"},{"key":"e_1_3_7_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2022.116897"},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12590"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25129-w"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2518"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470151808.sc04a08s32"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2016.07.018"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1089\/cell.2019.0107"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2025.04.062"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.119206"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.09.003"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-59575-1.00003-X"},{"key":"e_1_3_7_67_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Guidance for industry: potency tests for cellular and gene therapy products. Docket number: FDA-2008-D-0520. US Food and Drug Administration. 2011 [cited 2025 Dec 1] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/potency-tests-cellular-and-gene-therapy-products"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107623"},{"key":"e_1_3_7_69_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research (HHS\/FDA\/CDER\/CBER). Q5A(R2) viral safety evaluation of biotechnology products derived from cell lines of human or animal origin: guidance for industry. Revision 2. Docket number: FDA-2022-D-2512. US Food and Drug Administration. 2024 [cited 2025 Dec 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/q5ar2-viral-safety-evaluation-biotechnology-products-derived-cell-lines-human-or-animal-origin"},{"key":"e_1_3_7_70_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for Veterinary Medicine (CVM) Center for Devices and Radiological Health (CDRH) Office of Regulatory Affairs (ORA). Guidance for industry: Pyrogen and endotoxins testing: questions and answers. US Food and Drug Administration. 2012 [cited 2025 Dec 1] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/guidance-industry-pyrogen-and-endotoxins-testing-questions-and-answers"},{"key":"e_1_3_7_71_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Preclinical assessment of investigational cellular and gene therapy products. Docket number: FDA-2012-D-1038. US Food and Drug Administration. 2013 [cited 2025 Dec 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/preclinical-assessment-investigational-cellular-and-gene-therapy-products"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08753-5"},{"issue":"6","key":"e_1_3_7_73_1","first-page":"3490","article-title":"Real-time observation of pancreatic beta cell differentiation from human induced pluripotent stem cells","volume":"11","author":"Wang Q","year":"2019","unstructured":"Wang Q, Donelan W, Ye H, et al. Real-time observation of pancreatic beta cell differentiation from human induced pluripotent stem cells. Am J Transl Res. 2019;11(6):3490.","journal-title":"Am J Transl Res"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1163"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02005"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2025.103889"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2025.103834"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101711"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114994"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.707881"},{"key":"e_1_3_7_81_1","first-page":"237","article-title":"Endoderm differentiation from human pluripotent stem cells","volume":"2016","author":"Kumar N","unstructured":"Kumar N, Brafman D, Willert K. Endoderm differentiation from human pluripotent stem cells. Work STEM Cells. 2016:237\u2013255.","journal-title":"Work STEM Cells"},{"key":"e_1_3_7_82_1","unstructured":"Landshammer A. Study of the human SOX17 locus and its genetic determinants in definitive endoderm [Doctoral dissertation]. Berlin: Freie Universit\u00e4t Berlin; 2022."},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3326"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ydbio.2006.05.019"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.09.002"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1700307114"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2428"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.02175"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1007\/7651_2015_230"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-017-9783-8"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01171-8"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbiotec.2021.02.009"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23525-x"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037004"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.24683"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.20.13590"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.4.1607"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-81735-1"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0375-3"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184601"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00831-0"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0271-4"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(89)90191-7"},{"key":"e_1_3_7_104_1","doi-asserted-by":"publisher","DOI":"10.5912\/jcb695"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.18609\/cgti.2021.076"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1039\/D2SM00018K"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6960-9"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10895-023-03382-1"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2022.09.005"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1186\/1423-0127-17-36"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2012.08.040"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2011.10.002"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-014-9580-6"},{"key":"e_1_3_7_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8212"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.3383"},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mod.2011.08.001"},{"key":"e_1_3_7_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2024.10.001"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.10.001"},{"key":"e_1_3_7_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2008.08.019"},{"key":"e_1_3_7_120_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.127.22.4905"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5026793"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1479"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2153-1"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-2270"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2019.08.009"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05672-y"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21735"},{"key":"e_1_3_7_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2023.10.005"},{"key":"e_1_3_7_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.681"},{"key":"e_1_3_7_130_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/298163"},{"key":"e_1_3_7_131_1","first-page":"237","article-title":"Endoderm differentiation from human pluripotent stem cells","volume":"2016","author":"Kumar N","unstructured":"Kumar N, Brafman D, Willert K. Endoderm differentiation from human pluripotent stem cells. Work STEM Cells. 2016:237\u2013255.","journal-title":"Work STEM Cells"},{"key":"e_1_3_7_132_1","doi-asserted-by":"publisher","DOI":"10.51335\/organoid.2024.4.e4"},{"key":"e_1_3_7_133_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1091757"},{"key":"e_1_3_7_134_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-020-01977-0"},{"key":"e_1_3_7_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2010.05.015"},{"key":"e_1_3_7_136_1","doi-asserted-by":"publisher","DOI":"10.1007\/7651_2020_323"},{"key":"e_1_3_7_137_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0759-z"},{"key":"e_1_3_7_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2015.02.017"},{"key":"e_1_3_7_139_1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.162496.1"},{"key":"e_1_3_7_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48647-w"},{"key":"e_1_3_7_141_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103556"},{"key":"e_1_3_7_142_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2025.06.004"},{"key":"e_1_3_7_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2580-5"},{"key":"e_1_3_7_144_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136713"},{"key":"e_1_3_7_145_1","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v13.i3.193"},{"key":"e_1_3_7_146_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.002691"},{"key":"e_1_3_7_147_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0694-z"},{"key":"e_1_3_7_148_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K07E-041"},{"key":"e_1_3_7_149_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052181"},{"key":"e_1_3_7_150_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-020-02383-4"},{"key":"e_1_3_7_151_1","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.5C6684.2005"},{"key":"e_1_3_7_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040"},{"key":"e_1_3_7_153_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.12.012"},{"issue":"2","key":"e_1_3_7_154_1","first-page":"251","article-title":"Introduction to immunocytochemistry","volume":"202","author":"Davies J","year":"2003","unstructured":"Davies J. Introduction to immunocytochemistry. J Anat. 2003;202(2):251.","journal-title":"J Anat"},{"key":"e_1_3_7_155_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00560-y"},{"key":"e_1_3_7_156_1","doi-asserted-by":"publisher","DOI":"10.1159\/000329864"},{"key":"e_1_3_7_157_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03390-8"},{"key":"e_1_3_7_158_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57787-0"},{"key":"e_1_3_7_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111238"},{"key":"e_1_3_7_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2015.01.007"},{"key":"e_1_3_7_161_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01606466"},{"key":"e_1_3_7_162_1","doi-asserted-by":"publisher","DOI":"10.3390\/s18041271"},{"key":"e_1_3_7_163_1","doi-asserted-by":"publisher","DOI":"10.2144\/000112776"},{"key":"e_1_3_7_164_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep04488"},{"key":"e_1_3_7_165_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007855"},{"key":"e_1_3_7_166_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12193"},{"key":"e_1_3_7_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.08.010"},{"key":"e_1_3_7_168_1","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szae058"},{"key":"e_1_3_7_169_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-019-05100-2"},{"key":"e_1_3_7_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.05.019"},{"key":"e_1_3_7_171_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2015.08.001"},{"key":"e_1_3_7_172_1","first-page":"1","article-title":"Best practices for the development of pluripotent stem cell-derived therapies","author":"International Society For Stem Cell Research","year":"2025","unstructured":"International Society For Stem Cell Research. Best practices for the development of pluripotent stem cell-derived therapies. ISSCR. 2025;1\u2013339.","journal-title":"ISSCR"},{"key":"e_1_3_7_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2024.09.003"},{"key":"e_1_3_7_174_1","volume-title":"ICH","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","year":"2005","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Validation of analytical procedures: text and methodology Q2(R2). In: ICH; 2005 [cited 2025 Dec 1] Available from: https:\/\/www.ich.org\/page\/quality-guideline"},{"key":"e_1_3_7_175_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2022.09.010"},{"key":"e_1_3_7_176_1","doi-asserted-by":"publisher","DOI":"10.1177\/0963689717720281"},{"key":"e_1_3_7_177_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2020.10.004"},{"key":"e_1_3_7_178_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-010-9333-z"},{"key":"e_1_3_7_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145048"},{"key":"e_1_3_7_180_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-128-8_3"},{"key":"e_1_3_7_181_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-010-9352-9"},{"key":"e_1_3_7_182_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27931"},{"key":"e_1_3_7_183_1","doi-asserted-by":"publisher","DOI":"10.2217\/rme.11.5"},{"key":"e_1_3_7_184_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12094"},{"key":"e_1_3_7_185_1","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020197"},{"key":"e_1_3_7_186_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00008.2017"},{"key":"e_1_3_7_187_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164457"},{"key":"e_1_3_7_188_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003897"},{"key":"e_1_3_7_189_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00079.2004"},{"key":"e_1_3_7_190_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115892"},{"key":"e_1_3_7_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101212"},{"key":"e_1_3_7_192_1","volume-title":"Cell culture contamination. Cancer cell culture: methods and protocols","author":"Stacey GN","year":"2011","unstructured":"Stacey GN. Cell culture contamination. Cancer cell culture: methods and protocols. Totowa (NJ): Humana Press; 2011."},{"key":"e_1_3_7_193_1","doi-asserted-by":"publisher","DOI":"10.37745\/ejbmsr.2013\/vol12n23251"},{"key":"e_1_3_7_194_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01492-19"},{"key":"e_1_3_7_195_1","volume-title":"ICH","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","year":"2023","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin Q5A(R2). In: ICH; 2023 [cited 2025 Dec 1] Available from: https:\/\/www.ich.org\/page\/quality-guidelines"},{"key":"e_1_3_7_196_1","doi-asserted-by":"publisher","DOI":"10.1134\/S0003683824604943"},{"key":"e_1_3_7_197_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470054581.eib454"},{"key":"e_1_3_7_198_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106724"},{"key":"e_1_3_7_199_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107669"},{"issue":"1","key":"e_1_3_7_200_1","first-page":"42","article-title":"PCR-based detection of mycoplasma species","volume":"44","author":"Sung H","year":"2006","unstructured":"Sung H, Kang SH, Bae YJ, et al. PCR-based detection of mycoplasma species. J Microbiol. 2006;44(1):42\u201349.","journal-title":"J Microbiol"},{"issue":"2","key":"e_1_3_7_201_1","first-page":"26","article-title":"Using ddPCR to detect mycoplasma contamination","volume":"2021","author":"White M","year":"2021","unstructured":"White M. Using ddPCR to detect mycoplasma contamination. Pharm Technol Biologics Sterile Drug Manuf. 2021;2021(2):26\u201332.","journal-title":"Pharm Technol Biologics Sterile Drug Manuf"},{"key":"e_1_3_7_202_1","unstructured":"U.S. Pharmacopeia Convention. Sterility tests (USP71). United states pharmacopeia and National formulary (USP 32\/NF 27). Bethesda (MD): United States Pharmacopeia Convention; n.d."},{"key":"e_1_3_7_203_1","first-page":"155","volume-title":"Sterility. European pharmacopoeia","author":"EDQM (European Directorate for the Quality of Medicines and Healthcare) Council","year":"2014","unstructured":"EDQM (European Directorate for the Quality of Medicines and Healthcare) Council. Biological test. In: Sterility. European pharmacopoeia. 8th ed. Strasbourg, France: EDQM Council of Europe; 2014. p. 155.","edition":"8"},{"key":"e_1_3_7_204_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-12-255"},{"key":"e_1_3_7_205_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115028"},{"key":"e_1_3_7_206_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10101882"},{"key":"e_1_3_7_207_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix881"},{"key":"e_1_3_7_208_1","doi-asserted-by":"publisher","DOI":"10.33611\/trs.2020-017"},{"key":"e_1_3_7_209_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.021"},{"key":"e_1_3_7_210_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.101.3.409"},{"key":"e_1_3_7_211_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2021.114316"},{"key":"e_1_3_7_212_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-014-3449-3"},{"key":"e_1_3_7_213_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12257-009-3137-6"},{"key":"e_1_3_7_214_1","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.825257"},{"key":"e_1_3_7_215_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.03.026"},{"key":"e_1_3_7_216_1","doi-asserted-by":"publisher","DOI":"10.1111\/jmi.13370"},{"key":"e_1_3_7_217_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2005.12.001"},{"key":"e_1_3_7_218_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.242579699"},{"key":"e_1_3_7_219_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Microbiological quality considerations in non-sterile Drug manufacturing guidance for industry. Docket number: FDA-2021-D-0432. US Food and Drug Administration. 2021 [cited 2025 Dec 1] Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/microbiological-quality-considerations-non-sterile-drug-manufacturing"},{"key":"e_1_3_7_220_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429201400-56"},{"key":"e_1_3_7_221_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113246"},{"key":"e_1_3_7_222_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). ICH topic Q5D: quality of biotechnological products \u2014 derivation and characterisation of cell substrates used for production of biotechnological\/biological products. Step 5 (CPMP\/ICH\/294\/95). European Medicines Agency. 2006 [cited 2025 Dec 1]. Available from: https:\/\/www.ema.europa.eu\/en\/ich-q5d-derivation-characterisation-cell-substrates-used-production-biotechnological-biological-products-scientific-guideline"},{"key":"e_1_3_7_223_1","first-page":"1","article-title":"Karyotype analysis and chromosome banding","author":"Bickmore WA","year":"2001","unstructured":"Bickmore WA. Karyotype analysis and chromosome banding. Encycl Life Sci. 2001;1\u20136.","journal-title":"Encycl Life Sci"},{"key":"e_1_3_7_224_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-011-9285-2"},{"key":"e_1_3_7_225_1","doi-asserted-by":"publisher","DOI":"10.1086\/421250"},{"key":"e_1_3_7_226_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5825"},{"key":"e_1_3_7_227_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07236-x"},{"key":"e_1_3_7_228_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2019.12.004"},{"key":"e_1_3_7_229_1","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2020-0147"},{"key":"e_1_3_7_230_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1509"},{"key":"e_1_3_7_231_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2019.01.013"},{"key":"e_1_3_7_232_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10577-019-09623-z"},{"key":"e_1_3_7_233_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2012.08.001"},{"key":"e_1_3_7_234_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2024.105769"},{"key":"e_1_3_7_235_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2019.10.001"},{"key":"e_1_3_7_236_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Preclinical assessment of investigational cellular and gene therapy products. Docket number: FDA-2012-D-1038. U.S. Food and Drug Administration. 2013 [cited 2025 Dec 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/preclinical-assessment-investigational-cellular-and-gene-therapy-productsoo"},{"key":"e_1_3_7_237_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reth.2014.12.001"},{"key":"e_1_3_7_238_1","doi-asserted-by":"publisher","DOI":"10.1177\/0192623314559104"},{"key":"e_1_3_7_239_1","unstructured":"Committee for Advanced Therapies (CAT). Reflection paper on stem cell-based products. EMA\/CAT\/571134\/2009. European Medicines Agency. 2011 [cited 2025 Dec 1] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-reflection-paper-stem-cell-based-medicinal-products_en.pdf"},{"key":"e_1_3_7_240_1","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Biologics Evaluation and Research (HHS\/FDA\/CBER). Considerations for allogeneic pancreatic islet cell products: guidance for industry. Docket number: FDA-2008-D-0293. U.S. Food and Drug Administration. 2009 [cited 2025 Dec 1]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-allogeneic-pancreatic-islet-cell-products"},{"key":"e_1_3_7_241_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.78"},{"key":"e_1_3_7_242_1","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2011.0665"},{"key":"e_1_3_7_243_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13232"},{"key":"e_1_3_7_244_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2021.06.027"}],"container-title":["Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460751.2026.2634720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:03:58Z","timestamp":1774271038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460751.2026.2634720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":242,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/17460751.2026.2634720"],"URL":"https:\/\/doi.org\/10.1080\/17460751.2026.2634720","relation":{},"ISSN":["1746-0751","1746-076X"],"issn-type":[{"value":"1746-0751","type":"print"},{"value":"1746-076X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=irme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}